Detalhe da pesquisa
1.
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
Med J Aust
; 214(4): 179-185, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33538019
2.
Establishing thresholds and parameters for pandemic influenza severity assessment, Australia.
Bull World Health Organ
; 96(8): 558-567, 2018 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30104796
3.
The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021.
Med J Aust
; 217(1): 43-45, 2022 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35598097
4.
Australian vaccine preventable disease epidemiological review series: tetanus 2003-2019.
Commun Dis Intell (2018)
; 472023 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37857556
5.
Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020.
PLoS One
; 17(7): e0265858, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35793307
6.
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
Open Forum Infect Dis
; 9(3): ofac002, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35169588
7.
Evidence for an increase in the intensity of inter-seasonal influenza, Queensland, Australia, 2009-2019.
Influenza Other Respir Viruses
; 15(3): 396-406, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33369256
8.
Establishing thresholds and parameters for pandemic influenza severity assessment, Australia
Bull. W.H.O. (Print)
; 96(8): 558-567, 2018-8-01.
Artigo
Inglês
| WHOLIS | ID: who-274081